skip to Main Content
  • This page as PDF

Clinical Trial Data Transparency: Explaining Governance Considerations for Public Data Sharing


Avalere recognizes the current landscape and the drive of data transparency. This session provides an overview of the clinical trial data transparency discussion in the EU. In addition, we will review some of the key barriers to effectively governing the process for collecting, storing, securing, authorizing access, and auditing the data from a regulatory perspective.

Back To Top